Loading stock…

Elanco Animal Health Incorporated (ELAN) Stock Verdict & Ratings | Investment Bastion

Stock Verdict·Updated today

Elanco Animal Health Incorporated

ELANMarket cap $11BPrice $22.5

Country🇺🇸United States

SectorHealthcare

IndustryPharmaceuticals

Makes medicines and vaccines that keep pets and livestock healthy, from flea treatments to cattle antibiotics. Spun off from Eli Lilly in 2018, it's now one of the largest animal health companies on the planet.

In Bastion Portfolios?

52W Return+5%Global Market +16%?

01Key Ratings

How does this stock score across Bastion factors?

Growth

Historical Revenue

Rev CAGR (3y)+2%4

Revenue Forecast

Rev CAGR (1y)+9%6

Rev CAGR (3y)+6%5

Rev CAGR (5y)+6%5

Earnings Forecast

EPS Growth Y+10%5

EPS Growth Y+2+13%7

EPS Growth Y+3+14%7

Quality

Margins

EBIT Margin7%3

Net Income Margin-4%2

Free Cash Flow Margin8%5

Debt

Net Debt/EBITDA3.42

Efficiency

ROE-3%2

ROA-1%2

Earnings Stability44

GEAR+VERY WEAK14

Overall rating across all five factors

Value

Price Multiples

P/E Ratio (Forward)194

P/E Ratio (Forward 3y)154

P/BV1.77

EV Multiples

EV/EBITDA Fwd154

EV/EBIT Fwd175

Yield

Free Cash Flow Yield3.4%5

Dividend Yieldna–

Momentum

Short term

1 month return-4%5

3 month return-8%4

YTD return-0%5

Mid term

Price vs 52wHigh81%5

1 year return+12%6

Long term

3 year return+138%8

5 year return-32%2

Risk Shield

Price Risk

Beta1.04

Volatility42%4

Free Cash Flow

Free Cash Flow Margin8%5

Free Cash Flow Yield3.4%5

Quality

ROCE3%2

Earnings Stability44

Net Debt/EBITDA3.42

02Growth

Is it actually growing, and how fast?

ELANElanco Animal Health

Revenue FY25$4.7B

GROWTH RATING↗

AVERAGE47 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+2%4

Revenue, next 1Y+9%6

Revenue, next 3Y, CAGR+6%5

Revenue, next 5Y, CAGR+6%5

EARNINGS FORECAST▾SCORE

EPS growth, FY26E0%5

EPS growth, FY27E+13%7

EPS growth, FY28E+14%7

GROWTH ASSESSMENT

STRENGTHS

Revenue grew 2%/yr over the last 3 years and is set to grow 6%/yr from here.

WATCH

A mid-pack grower, ahead of 47% of companies worldwide.

Revenue is set to grow 6%/yr over the next 3 years, in line with the market.5/10

Over five years revenue is set to grow 6%/yr, about average versus companies worldwide.5/10

WEAKNESSES

The company is loss-making, so its revenue growth is not backed by profit yet.

BOTTOM LINE

Steady Grower

A middle-of-the-pack grower that's speeding up. The one thing to watch: the company is not profitable yet.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

AVERAGE38 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-4%5

3-month return-8%4

YTD return-0%5

MID & LONG-TERM▾SCORE

% of 52-week high81%5

1-year return+12%6

3-year return+138%8

5-year return-32%2

MOMENTUM ASSESSMENT

STRENGTHS

None flagged.

WATCH

Average long-term results. Multi-year returns are middling (+138% over three years and -32% over five), roughly average for the market.

It's up 12% over the past year, but 19% below its 52-week high. That is a touch ahead of the market.

Returns sit at the market level over the past month (-4%), over three months (-8%) and so far this year (+0%).

WEAKNESSES

None flagged.

BOTTOM LINE

Mixed Momentum

Horizons disagree or sit near the middle of the pack. Momentum investors may want a clearer trend before sizing up.

04Value

Are you paying a fair price for it?

Stop guessing on Elanco Animal Health Incorporated. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Loading charts…

02Growth

Is it actually growing, and how fast?

ELANElanco Animal Health

Revenue FY25$4.7B

GROWTH RATING↗

AVERAGE47 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+2%4

Revenue, next 1Y+9%6

Revenue, next 3Y, CAGR+6%5

Revenue, next 5Y, CAGR+6%5

EARNINGS FORECAST▾SCORE

EPS growth, FY26E0%5

EPS growth, FY27E+13%7

EPS growth, FY28E+14%7

GROWTH ASSESSMENT

STRENGTHS

Revenue grew 2%/yr over the last 3 years and is set to grow 6%/yr from here.

WATCH

A mid-pack grower, ahead of 47% of companies worldwide.

Revenue is set to grow 6%/yr over the next 3 years, in line with the market.5/10

Over five years revenue is set to grow 6%/yr, about average versus companies worldwide.5/10

WEAKNESSES

The company is loss-making, so its revenue growth is not backed by profit yet.

BOTTOM LINE

Steady Grower

A middle-of-the-pack grower that's speeding up. The one thing to watch: the company is not profitable yet.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

AVERAGE38 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-4%5

3-month return-8%4

YTD return-0%5

MID & LONG-TERM▾SCORE

% of 52-week high81%5

1-year return+12%6

3-year return+138%8

5-year return-32%2

MOMENTUM ASSESSMENT

STRENGTHS

None flagged.

WATCH

Average long-term results. Multi-year returns are middling (+138% over three years and -32% over five), roughly average for the market.

It's up 12% over the past year, but 19% below its 52-week high. That is a touch ahead of the market.

Returns sit at the market level over the past month (-4%), over three months (-8%) and so far this year (+0%).

WEAKNESSES

None flagged.

BOTTOM LINE

Mixed Momentum

Horizons disagree or sit near the middle of the pack. Momentum investors may want a clearer trend before sizing up.

04Value

Are you paying a fair price for it?

Stop guessing on Elanco Animal Health Incorporated. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community